Dr Gaia Kiru

Faculty of Medicine, School of Public Health

Head of Operations and Partnerships

Contact

Location

Stadium HouseWhite City Campus

Summary

Dr Gaia Kiru joined Imperial College in 2007 and she currently holds the position of Head of Operations & Partnerships at ICTU-Global, an Academic Research Organisation based within the Imperial Clinical Trials Unit (ICTU), in the School of Public Health within the Faculty of Medicine at Imperial College London.

Gaia has over 17 years experience of managing both academic and industry sponsored research projects, both in the UK and internationally - including study design, ethics and regulatory submissions, project management, budget control, pharmacovigilance, monitoring, data management, drug supply and recruitment and retention of research participants.

Although her background and expertise lies mainly in the cardiovascular field, she has worked in several therapeutic areas including medical devices, oncology, respiratory, orthopaedics, haematology and vaccines.

Qualifications

PhD - Imperial College London. Thesis titled: Investigating the roles of central and peripheral blood pressure and blood pressure variability on the size and growth of Abdominal Aortic Aneurysms.

MBA Health Services Management - University of Plymouth

MSc Pharmacology - Kings College London

BSc Human Biology - Kings College London

Publications

Journals

Vallejo-Vaz AJ, Bray S, Villa G, et al.Vallejo-Vaz AJ, Bray S, Villa G, Brandts J, Kiru G, Murphy J, Banach M, De Servi S, Gaita D, Gouni-Berthold I, Hovingh GK, Jozwiak JJ, Jukema JW, Kiss RG, Kownator S, Iversen HK, Maher V, Masana L, Parkhomenko A, Peeters A, Clifford P, Raslova K, Siostrzonek P, Romeo S, Tousoulis D, Vlachopoulos C, Vrablik M, Catapano AL, Poulter NR, Ray KK close, 2023, Implications of ACC/AHA Versus ESC/EAS LDL-C recommendations for residual risk reduction in ASCVD: a simulation study from DA VINCI, Cardiovascular Drugs and Therapy, Vol:37, ISSN:0920-3206, Pages:941-953

Beaney T, Wang W, Schlaich MP, et al.Beaney T, Wang W, Schlaich MP, Schutte AE, Stergiou GS, Alcocer L, Alsaid J, Diaz AB, Hernandez-Hernandez R, Ishaq M, Jozwiak J, Khan N, Kiru G, McCardle H, Odili AN, Pyun WB, Romero CA, Wang J, Poulter NR, MMM Investigators close, 2023, Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign, Journal of Hypertension, Vol:41, ISSN:0263-6352, Pages:1446-1455

Ray K, Molemans B, Schoonen WM, et al.Ray K, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, Murphy J, Banach M, De Servi S, Gaita D, Gouni-Berthold I, Hovingh GK, Jozwaik JJ, Jukema JW, Gabor Kiss R, Kownator S, Iversen HK, Maher V, Masana L, Parkhomenko A, Peeters A, Clifford P, Raslova K, Siostrzonek P, Romeo S, Tousoulis D, Vlachopoulos C, Vrablik M, Catapano AL, Poulter NR, DA VINCI study close, 2021, EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study, European Journal of Preventive Cardiology, Vol:28, ISSN:2047-4873, Pages:1279-1289

Bicknell CD, Kiru G, Falaschetti E, et al.Bicknell CD, Kiru G, Falaschetti E, Powell J, Poulter N, the AARDVARK Collaborators close, 2016, An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: A randomised placebo controlled trial (AARDVARK), European Heart Journal, Vol:37, ISSN:1522-9645, Pages:3213-3221

Conference

Murphy J, Durkina M, Jadav P, et al.Murphy J, Durkina M, Jadav P, Kiru G close, 2019, An assessment of feasibility and cost-effectiveness of remote monitoring on a multicentre observational study, BMC

Author Web Link

More Publications